{"id":22819,"date":"2015-11-16T11:03:17","date_gmt":"2015-11-16T10:03:17","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=22819"},"modified":"2015-11-16T17:35:13","modified_gmt":"2015-11-16T16:35:13","slug":"chiesi-e-recordati-pronte-a-nuove-acquisizioni","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/chiesi-e-recordati-pronte-a-nuove-acquisizioni\/","title":{"rendered":"Chiesi and Recordati ready for new acquisitions"},"content":{"rendered":"

Pharmaceuticals: Chiesi ready for new shopping<\/span><\/h1>\n

R\"\"OMA (MF-DJ) \u2013 There could be some news for Chiesi in the coming months. The president of the group, Alberto Chiesi, told CorrierEconomia, explaining that \u201cwe are interested in taking over innovative projects, products and companies. In particular we are interested in the areas of rare diseases and specialist diseases, both in the USA and in Europe. In the next few months we want to carry out some acquisitions\u201d. \u201cWe are looking at something concrete - continued Chiesi- outside of Italy\u201d. So far the family has gone on its own. \u201cOf course -explained the chairman- if we were faced with the opportunity of acquiring companies of our size, if not larger, we would be forced to resort to external capital, and therefore to consider options such as the Stock Exchange. But I think we can go one step at a time." Also because on major mergers, Chiesi defined himself as \u201csceptical. I don't think there are many mergers that have created real and useful synergies for the company, in most cases we end up adding up turnovers and organisations\u201d.<\/p>\n

MF-DJ NEWS 1609:37 Nov 2015 \u2013 CorSera 16\/11\/2015<\/span><\/a><\/p>\n

Recordati, now two acquisitions. ally? It doesn't have to be taboo<\/span><\/h1>\n

\"\"The Monday insert of Corriere della Sera interviewed Giovanni Recordati, number one of the homonymous company listed on Piazza Affari. The manager of the pharmaceutical company indicated that the top management is working to complete two acquisitions in Europe over the next few quarters \u201cto strengthen the group in the business of traditional products, those over the counter. But also the unreimbursed OTCs\u201d. The operations will not be large but will be "very targeted", exploiting available cash for 240 million euros against long-term debts for 300 million. Recorati's goal is to bring the group's turnover from the 1.04 billion euro estimated for the current year to 1.2 billion. Giovanni Recordati highlighted that "in the last 15 years the group has invested one billion in acquisitions and distributed dividends of 500 million".<\/p>\n

SoldiOnLine \u2013 11\/16\/2015<\/span><\/a><\/p>\n

Related news:\u00a0Recordati: president, ready for 2 acquisitions<\/span><\/a><\/p>\n

LEO Pharma acquires Astellas dermatological medicines<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"

Farmaceutica: Chiesi pronta a nuovo shopping ROMA (MF-DJ)–Nei prossimi mesi potrebbero esserci novita’ per Chiesi. Lo ha detto al CorrierEconomia il presidente del gruppo, Alberto Chiesi, spiegando che “siamo interessati a rilevare progetti innovativi, prodotti e aziende. In particolare siamo interessati alle aree delle malattie rare e delle malattie specialistiche, sia negli Usa che in …<\/p>","protected":false},"author":4,"featured_media":22827,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[53],"class_list":["post-22819","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-fusioniacquisizioni"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/22819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=22819"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/22819\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/22827"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=22819"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=22819"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=22819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}